Topical AmphiMatrix

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	2

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00577304 (ClinicalTrials.gov)	December 2007	18/12/2007	A Study of a TopicalForm of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's P ...	A Study of a TopicalFormulation of Nitroglycerin, MQX-503, and Matching Vehicle in the Treatment and ...	Raynaud's Disease;Raynaud's Disease Secondary to Scleroderma;Raynaud's Disease Secondary to Other Au ...	Drug: Nitroglycerin;Drug: Topical AmphiMatrix	MediQuest Therapeutics	NULL	Active, not recruiting	15 Years	70 Years	Both	200	Phase 3	United States
2	NCT00419419 (ClinicalTrials.gov)	December 2006	4/1/2007	Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon	Phase III In-Life Study of a TopicalGel Formulation of Nitroglycerin, MQX-503, and Matching Placebo ...	Raynaud's Disease;Scleroderma;Autoimmune Diseases	Drug: Topical AmphiMatrix with nitroglycerin (MQX-503)	MediQuest Therapeutics	NULL	Completed	18 Years	70 Years	Both	80	Phase 3	United States;Sweden;United Kingdom

First Previous1Next Last